A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

E P Sampaio, Euzenir Nunes Sarno, Ruth Galilly et al. · The Journal of Experimental Medicine · 1991 · 1.2K citations · Full text

Toxic Effects, Immune Regulation, Immunology +22

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

André L. Moreira, E P Sampaio, A Zmuidzinas et al. · The Journal of Experimental Medicine · 1993 · 1.1K citations · Full text

Apoptosis, Immunology, Cell Death +16

Medical progress:sarcoidosis

EN Li-ping, Pumc Hospita · Zhonghua linchuang mianyi he biantai fanying zazhi · 2008 · 719 citations

Improved Discriminative and Evaluative Capability of a Refined Version of Skindex, a Quality-of-Life Instrument for Patients With Skin Diseases

Mary‐Margaret Chren · Archives of Dermatology · 1997 · 474 citations

Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases

Mery Margaret Chren · Archives of Dermatology · 1997 · 446 citations

Refined Version, Evaluative Capability, Skin Diseases +6